Stada Names Novartis Exec as New CEO, It's Fifth Leader Since 2016 Post author:Sam Post published:January 31, 2018 Post category:BioPharma Today STADA announced the appointment of Peter Goldschmidt as new CEO and chairman of the board. Source: BioSpace You Might Also Like Cambridge's WuXi NextCODE Completes a Whopping $240 Million Funding Round September 6, 2017 Struggling Teva Loses Top R&D Exec To Eli Lilly, Novartis AG-Backed Cavion August 14, 2017 Bristol-Myers Squibb Could Finally Go on the Market; Rumored Suitors Include Gilead, Pfizer, Novartis AG and Roche February 13, 2017
Bristol-Myers Squibb Could Finally Go on the Market; Rumored Suitors Include Gilead, Pfizer, Novartis AG and Roche February 13, 2017